Invention Grant
- Patent Title: Heterocyclic compounds as RSV inhibitors
-
Application No.: US16379881Application Date: 2019-04-10
-
Publication No.: US10975094B2Publication Date: 2021-04-13
- Inventor: Jianming Yu , Solymar Negretti-Emmanuelli , In Jong Kim , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D495/14
- IPC: C07D495/14 ; C07D493/14 ; C07D413/14 ; C07D493/10 ; A61P31/16 ; C07D519/00
Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20190315766A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS Public/Granted day:2019-10-17
Information query
